Technology
Health
Biotechnology

Epizyme

$12.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-0.39%) Today
$0.00 (0.00%) As of 4:08 PM EDT after-hours

Why Robinhood?

You can buy or sell Epizyme and other stocks, options, ETFs, and crypto commission-free!

About EPZM

CEO
Employees
124
Headquarters
Founded
2007
Market Cap
1.16B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
580.93K
High Today
$12.89
Low Today
$12.34
Open Price
$12.77
Volume
462.73K
52 Week High
$16.59
52 Week Low
$5.14

Collections

Technology
Health
Biotechnology
Cancer Prevention
Medical
Biopharmaceutical
Pharmaceutical
2013 IPO

EPZM News

Seeking AlphaJun 21

Updated Epizyme data from tazemetostat Phase 2 trial 'positive'

616

EPZM Earnings

-$0.61
-$0.50
-$0.40
-$0.29
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, Pre-Market

More EPZM News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.